Related Experiment Video
Updated: Jun 6, 2026
09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Management of skull base metastases
Roukoz B Chamoun1, Franco DeMonte
1Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
Neurosurgery Clinics of North America
|November 27, 2010
Summary
Skull base metastases (SBM) are rare tumors. Early diagnosis and radiotherapy are key, with surgery reserved for select cases based on patient status and disease control.
Area of Science:
- Oncology
- Neurosurgery
- Radiotherapy
Background:
- Skull base metastases (SBM) are uncommon tumors with limited research.
- Clinical syndromes associated with SBM require a high index of suspicion for diagnosis.
Purpose of the Study:
- To review the clinical presentation, diagnosis, and management of skull base metastases.
- To highlight the importance of early diagnosis and appropriate treatment strategies.
Main Methods:
- Review of existing literature on skull base metastases.
- Analysis of clinical syndromes and diagnostic challenges.
- Evaluation of current treatment modalities including radiotherapy, radiosurgery, chemotherapy, and surgery.
Main Results:
- Radiotherapy is the primary treatment for most SBM patients.
- Surgical resection is indicated for a small subset of patients with specific criteria.
- Management decisions are individualized, relying on clinical status, systemic disease control, lesion accessibility, and potential morbidity.
Conclusions:
- Effective management of SBM relies on early diagnosis and multidisciplinary expertise.
- Evidence-based guidelines and large trials are lacking, necessitating experienced clinical judgment.
- Treatment strategies are tailored to individual patient profiles and disease characteristics.